News
Stockhead on MSN38m
ASX Quarterly Health Wrap: Island completes Phase 2a/b mosquito-borne dengue trialIsland Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.
The FDA approved Botox for migraine headaches in October 2010, giving Allergan clearance to begin marketing its drug to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback